This brief discusses how drugs provided in inpatient hospital settings are covered and reimbursed for beneficiaries in traditional Medicare under current law. This is relevant for Medicare spending on COVID-19 patients who receive Gilead’s new antiviral drug remdesivir. We discuss the possible scenarios for hospitals and the Medicare program depending on different pricing levels for the drug.
- view as grid
- view as list
In response to COVID-19, all 50 states + DC are using emergency waivers and other authorities to make changes to their Medicaid programs. Check out details of these Medicaid emergency authorities on our tracker.
In this Axios column, Drew Altman shows that the majority of supporters don’t know how Medicare-for-all works, with both positive and negative implications for support if they knew more.
In this Axios column, Drew Altman looks at the polling trend on support for Medicare-for-all suggesting it may have crested as criticism has mounted. He considers what it means for the Democratic primary and continued debate for Medicare-for-all and other expansion proposals.
In response to the widespread concerns about the high numbers of coronavirus cases and deaths in long-term care (LTC) facilities, CMS recently implemented new COVID-19 data reporting requirements for all federally certified nursing facilities. The newly-released federal data builds on state-reported data that has been included in many, but not…
This brief provides an overview of how states currently reimburse providers and the challenges for Medicaid providers that have emerged from the pandemic and state budget issues. It presents new data on state actions to date to help bolster Medicaid providers dealing with the effects of COVID-19 and discusses support available for Medicaid providers from the federal provider relief fund.
The Department of Health and Human Services has said that it will use money from the provider relief fund created by the CARES Act to reimburse providers for care for uninsured COVID-19 patients. However, only about $62 billion remains in the fund and it is unclear how much money is being set aside to reimburse for care for the uninsured. This blog post reviews what the current status of the provider relief funding and raises questions about the administration’s policy of reimbursing for care for uninsured COVID-19 patients using the fund.
Total coronavirus cases in the U.S. are still climbing, and this week the cumulative total surpassed 2 million. There have been over 114,000 total confirmed deaths in the U.S.
In this Axios column, Drew Altman analyzes data from the New Hampshire exit poll showing that support for Medicare-for-all played a role in the primary while broader support for a more moderate plan may be a signal about the general election.